2.11000 USD
0.09
4.09%
Last update Dec 17, 3:59 PM EST
Market closed
Day range
2.11000
2.30000
Previous close
2.20000
Open
2.24000
Access this stock data via API
Subscribe
Sellas Life Sciences Group Inc.
2.11
0.09
4.09%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 4.2M 3.9M 3.2M 4.4M
Selling general and admin 2.9M 3.0M 2.9M 2.5M
Other operating expenses
Operating income -7.1M -6.9M -6.1M -6.9M
Non operating interest income
Income 292K 272K 250K 181K
Expense
Other income expense
Pretax income -6.8M -6.6M -5.8M -6.7M
Tax provision
Net income -6.8M -6.6M -5.8M -6.7M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 108.4M 98.6M 87.8M
Diluted average shares 108.4M 98.6M 87.8M
EBITDA -7.1M -6.9M -6.1M -6.9M
Net income from continuing op. -6.8M -6.6M -5.8M -6.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 57 minutes

01:02
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).